MannKind Corp. Stock
Price
Target price
€6.02
€6.02
3.000%
0.18
3.000%
€6.92
19.09.24 / Tradegate
WKN: A2DMZL / Symbol: MNKD / Name: MannKind / Stock / Biotechnology & Medical Research / Small Cap /
Please give a prediction to see the opinions of the community
sharewise uses Wisdom of crowds to gather information regarding a security. Wisdom of crowds works best if you do not see the predictions of others before giving your estimate. Please click one button to see how the community sees this security.
Your prediction
MannKind Corp. Stock
MannKind Corp. gained 3.000% today.
MannKind Corp. is currently one of the favorites of our community with 12 Buy predictions and no Sell predictions.
However, we have a potential of -0.27% for MannKind Corp. as the target price of 6 € is below the current price of 6.02 €.
Criterium "Worthwhile Investment for the next years" is seen as the biggest plus for MannKind Corp. stock. Negative votes have not been in the majority for any criteria for this stock
Pros and Cons of MannKind Corp. in the next few years
Pros
?
C******** o* t** e**********
?
B****
?
S********** s********
Cons
?
W********* I********* f** t** n*** y****
?
M***** P*******
?
G***** c******* t* c**********
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of MannKind Corp. vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| MannKind Corp. | 3.000% | 8.946% | 24.736% | 51.346% | 78.516% | 55.613% | 405.122% |
| Evolus Inc | 0.690% | 8.209% | 15.079% | 72.619% | 60.221% | 116.418% | - |
| Ardelyx Inc. | 2.780% | -4.516% | -0.739% | 42.819% | -7.093% | 375.221% | 21.783% |
| Coherus Bioscien. | 6.000% | -12.403% | -10.907% | -75.986% | -66.546% | -93.220% | -94.772% |
Comments
MannKind Co. (NASDAQ: MNKD) was upgraded by analysts at Leerink Partnrs to a "strong-buy" rating.
Show more
Ratings data for MNKD provided by MarketBeat
MannKind Co. (NASDAQ: MNKD) is now covered by analysts at Leerink Partners. They set an "outperform" rating and a $8.00 price target on the stock.
Show more
Ratings data for MNKD provided by MarketBeat
MannKind Co. (NASDAQ: MNKD) had its price target raised by analysts at Oppenheimer Holdings Inc. from $10.00 to $12.00. They now have an "outperform" rating on the stock.
Show more
Ratings data for MNKD provided by MarketBeat
News
MannKind (MNKD) Q2 2024 Earnings Call Transcript
Image source: The Motley Fool.
MannKind (NASDAQ: MNKD)Q2 2024 Earnings CallAug 07, 2024, 9:00 a.m. ET
Operator
Source Fool.com
MannKind (MNKD) Q1 2024 Earnings Call Transcript
Image source: The Motley Fool.
MannKind (NASDAQ: MNKD)Q1 2024 Earnings CallMay 08, 2024, 5:00 p.m. ET
Operator
Source Fool.com